Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Accredited Solutions | OTC Markets | Consumer Non-Cyclicals | Beverages | $1.45M | -0.4x | -0.01 | $0.0005 | -16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AAP | OTC Markets | Technology | Computers, Phones & Household Electronics | $1.15M | $0.0005 | 25% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
RAADR | OTC Markets | Technology | Software & IT Services | $10.19M | -3.3x | -2.01 | $0.001 | -36.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hiru Corporation | OTC Markets | Basic Materials | Metals & Mining | $7.95M | 0.4x | $0.003 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Palantir | NYSE | Technology | Software & IT Services | $97.37B | 237.6x | 0.29 | $43.40 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -37.9% Downside | Upgrade to Pro+ | |
Arcadium Lithium | NYSE | Basic Materials | Chemicals | $5.98B | 20.1x | -0.42 | $5.54 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.2% Upside | Upgrade to Pro+ | |
Authentic | OTC Markets | Consumer Cyclicals | Textiles & Apparel | $4.28M | -1.9x | -0.25 | $0.002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Imd Companies | OTC Markets | Financial | Investment Holding Companies | $25.84M | $0.006 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Peloton Interactive | NASDAQ | Consumer Cyclicals | Leisure Products | $2.04B | -3.6x | -0.06 | $5.40 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.3% Downside | Upgrade to Pro+ | |
Sangamo Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | $192.79M | -0.7x | 0.06 | $0.93 | 10.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
American Diversified | OTC Markets | Technology | Software & IT Services | $8.66M | $0.002 | -13.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Xpeng | NYSE | Consumer Cyclicals | Automobiles & Auto Parts | $11.01B | -9.6x | -0.45 | $11.63 | -9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17.1% Downside | Upgrade to Pro+ | |
MicroStrategy | NASDAQ | Technology | Software & IT Services | $41.01B | -161.8x | 1.15 | $201.67 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.9% Downside | Upgrade to Pro+ | |
Core Scientific | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | $3.41B | -4.7x | 0.22 | $12.97 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21% Upside | Upgrade to Pro+ | |
Marketing Worldwide | OTC Markets | Consumer Cyclicals | Automobiles & Auto Parts | $1.37M | 0x | $0.0002 | -20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Aurora Innovation | NASDAQ | Technology | Software & IT Services | $9.89B | -8.4x | -0.36 | $5.83 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -47.8% Downside | Upgrade to Pro+ | |
Affirm Holdings | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | $15.31B | -29.5x | -0.57 | $49.25 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.3% Downside | Upgrade to Pro+ | |
Clover Health Investments | NASDAQ | Healthcare | Healthcare Providers & Services | $2.06B | -16.4x | -0.31 | $4.12 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.4% Downside | Upgrade to Pro+ | |
Hanesbrands | NYSE | Consumer Cyclicals | Textiles & Apparel | $2.57B | -8.6x | -0.83 | $7.28 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17.1% Downside | Upgrade to Pro+ | |
Upstart | NASDAQ | Financial | Banking Services | $4.86B | -23.7x | -0.73 | $54.08 | 15% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -38.3% Downside | Upgrade to Pro+ | |
United Airlines Holdings | NASDAQ | Industrials | Passenger Transportation Services | $20.90B | 7.1x | 0.68 | $63.53 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Eos Energy Enterprises | NASDAQ | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | $682.09M | -4.5x | -0.07 | $3.16 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.4% Upside | Upgrade to Pro+ | |
Cyberlux Corp | OTC Markets | Industrials | Machinery, Tools, Heavy Vehicles, Trains & Ships | $48.16M | -31.5x | $0.008 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
BranchOut Food | NASDAQ | Consumer Non-Cyclicals | Food & Tobacco | $12.46M | -4.1x | -0.15 | $1.84 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evgo | NASDAQ | Utilities | Electrical Utilities & IPPs | $2.27B | -3.4x | -0.89 | $7.48 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13.6% Downside | Upgrade to Pro+ | |
Valley National | NASDAQ | Financial | Banking Services | $4.70B | 12.9x | -0.3 | $9.21 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
IONQ | NYSE | Technology | Software & IT Services | $2.32B | -13.6x | 0.36 | $10.84 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Gevo | NASDAQ | Energy | Renewable Energy | $462.48M | -6.4x | -0.26 | $2 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -58.7% Downside | Upgrade to Pro+ | |
Summit Therapeutics PLC | NASDAQ | Healthcare | Biotechnology & Medical Research | $14.87B | -97.6x | -1.1 | $20.25 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Revance The | NASDAQ | Healthcare | Pharmaceuticals | $540.89M | -1.7x | -0.06 | $5.14 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ |